Literature DB >> 7227442

The binding of tamoxifen to human mammary carcinoma cytosol.

R L Sutherland, L C Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7227442     DOI： 10.1016/0014-2964(80)90172-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

1.  Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.

Authors:  A C Tate; E R DeSombre; G L Greene; E V Jensen; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

2.  Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.

Authors:  R R Mehta; T K DasGupta
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 3.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

4.  A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues.

Authors:  Y Imanaka; S Tsuboi; N Kohno; Y Saitoh
Journal:  Jpn J Surg       Date:  1987-11

5.  Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.

Authors:  B S Katzenellenbogen; M A Miller; A Mullick; Y Y Sheen
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

Authors:  A E Lykkesfeldt; J K Larsen; I J Christensen; P Briand
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

7.  Effects of endocrine therapy on steroid-receptor content of breast cancer.

Authors:  R E Taylor; T J Powles; J Humphreys; R Bettelheim; M Dowsett; A J Casey; A M Neville; R C Coombes
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

8.  Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.

Authors:  G Milano; M C Etienne; M Frenay; R Khater; J L Formento; N Renee; J L Moll; M Francoual; M Berto; M Namer
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.